DrugPatentWatch Database Preview
Lab Hra Pharma Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for LAB HRA PHARMA, and what generic alternatives to LAB HRA PHARMA drugs are available?
LAB HRA PHARMA has one approved drug.
There are seven US patents protecting LAB HRA PHARMA drugs.
There are fifty-five patent family members on LAB HRA PHARMA drugs in twenty-eight countries.
Summary for Lab Hra Pharma
| International Patents: | 55 |
| US Patents: | 7 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Lab Hra Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lab Hra Pharma | ELLA | ulipristal acetate | TABLET;ORAL | 022474-001 | Aug 13, 2010 | AB | RX | Yes | Yes | 8,735,380 | Start Trial | Y | Start Trial | ||
| Lab Hra Pharma | ELLA | ulipristal acetate | TABLET;ORAL | 022474-001 | Aug 13, 2010 | AB | RX | Yes | Yes | 8,426,392 | Start Trial | Start Trial | |||
| Lab Hra Pharma | ELLA | ulipristal acetate | TABLET;ORAL | 022474-001 | Aug 13, 2010 | AB | RX | Yes | Yes | 8,962,603 | Start Trial | Start Trial | |||
| Lab Hra Pharma | ELLA | ulipristal acetate | TABLET;ORAL | 022474-001 | Aug 13, 2010 | AB | RX | Yes | Yes | 8,512,745 | Start Trial | Y | Start Trial | ||
| Lab Hra Pharma | ELLA | ulipristal acetate | TABLET;ORAL | 022474-001 | Aug 13, 2010 | AB | RX | Yes | Yes | 10,159,681 | Start Trial | Start Trial | |||
| Lab Hra Pharma | ELLA | ulipristal acetate | TABLET;ORAL | 022474-001 | Aug 13, 2010 | AB | RX | Yes | Yes | 9,283,233 | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for LAB HRA PHARMA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 30 mg | ➤ Subscribe | 2014-08-13 |
International Patents for Lab Hra Pharma Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Ukraine | 101863 | Start Trial |
| South Africa | 201104137 | Start Trial |
| Canada | 2757496 | Start Trial |
| European Patent Office | 3106167 | Start Trial |
| Japan | 5951480 | Start Trial |
| Australia | 2010237120 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
